Skip to main content
FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
Articles
Digital Health Literacy
Cut through health misinformation
Symptoms
What your body is telling you
Treatments
Protocols, prescriptions, therapies
Longevity
Medicine 3.0 strategies
Heart Health & Risk
Protect your heart & vessels
Metabolism
Insulin, blood sugar, weight
Hormones
TRT, thyroid, menopause, andropause
Performance
VO2 max, muscle, sleep, gut
Playbooks
Step-by-step frameworks
About
Meet Dr. Ash
Your Physician
GER·O·SPAN
Our Clinical Framework
What People Say
124 patient reviews across 6 platforms
Pricing & Membership
Transparent membership pricing
FAQ
Common Questions
Tell Dr. Ash
The Cholesterol Test Thats Often Missing from Standard Panels
Fishtown Medicine•8 min read

The Cholesterol Test Thats Often Missing from Standard Panels

Ashvin Vijayakumar MD

Medically Reviewed

Ashvin Vijayakumar MD•Updated December 29, 2024
On This Page
  • Why is ApoB more accurate than LDL cholesterol?
  • Why isnt ApoB on standard panels?
  • What is the Fishtown ApoB strategy?
  • 1. The Audit (ApoB and Lp(a))
  • 2. The Verification (CTA and Cleerly AI)
  • 3. The Architecture (Intervention)
  • Actionable Steps in Philly
  • ✦Key Takeaways
  • Common Questions
  • What is ApoB?
  • Is ApoB covered by insurance?
  • Do I have to take a statin if my ApoB is high?
  • What is a "good" ApoB range?
  • How is ApoB different from LDL cholesterol?
  • How often should I test ApoB?
  • Can lifestyle alone lower ApoB enough?
  • Does ApoB matter if my LDL is "normal"?
  • Deep Questions
  • How does insulin resistance change my cholesterol particles?
  • Where do GLP-1 medications fit in lowering ApoB?
  • What is the difference between a CAC score and a Cleerly CTA?
  • Why is soft plaque more dangerous than calcified plaque?
  • What is the role of inflammation in driving plaque?
  • When do you use PCSK9 inhibitors instead of statins?
  • What is bempedoic acid and who is it for?
  • Does fiber really lower ApoB?
  • How does ApoB relate to stroke risk?
  • Can children and young adults have high ApoB?
  • Why treat a 25-year-old's high ApoB instead of waiting?
  • What lifestyle changes lower ApoB the most?
  • Is there a link between ApoB and dementia?
  • Why do South Asians need ApoB and calcium testing earlier?
  • Why does Fishtown Medicine prioritize ApoB testing?
  • Scientific References
  • Related at Fishtown Medicine

Get a preventive doctor that knows you.

Consult Dr. Ash
TL;DR30-second take

ApoB (apolipoprotein B) is a protein on every cholesterol particle that can lodge in artery walls. It measures the number of harmful particles in your blood, which predicts heart attack risk far better than standard LDL cholesterol. We aim for ApoB under 80 mg/dL, lower for high-risk patients.

If your cholesterol came back normal and somebody told you that you're fine, you're in good company, and you may still be carrying more risk than that panel showed. Cardiovascular disease is the leading cause of death in Philadelphia and worldwide, and about half of the people who have a heart attack were walking around with "normal" LDL cholesterol on a standard panel. LDL cholesterol is a stand-in for risk, and it isn't a very good one. ApoB gets you closer to the truth.1

Why is ApoB more accurate than LDL cholesterol?

ApoB counts particles, and particles are what lodge in your artery walls. Picture your arteries as the Vine Street Expressway (I-676). The cholesterol on your panel (LDL-C) is the passengers riding in the cars, and ApoB is the cars themselves. The expressway backs up because of how many cars are on it, and your arteries build plaque the same way, while the passengers ride along either way.

(Lp(a) gets its own "Mad Max" version of this analogy in our Lp(a) article.)

So you can have low cholesterol, meaning few passengers, and a high ApoB, meaning a lot of small cars. That gap is called discordance, and it's the single biggest missed warning in modern cardiology.

Dr. Ash
"Every week we meet someone who was told their cholesterol is 'fine,' and then their ApoB comes back in the 90th percentile. There's a slow flame going in their arteries that nobody went looking for. We can put it out."

Why isnt ApoB on standard panels?

ApoB stays off most panels because the system was built to manage disease once it shows up rather than to prevent it. In a 15-minute insurance-based visit, your doctor gets pushed toward guidelines built on 10-year risk models, and those models don't start counting until something has already gone wrong. We worked in that system. We followed those guidelines ourselves, right up until the data on early atherosclerosis, which is plaque buildup, got too loud to ignore.

At Fishtown Medicine we have time, and we're free of insurance denial algorithms. That lets us practice Medicine 3.0 and treat your risk decades before it turns into a heart attack.

What is the Fishtown ApoB strategy?

We treat your arteries the way you'd treat a retirement account, where what you put in early compounds into something much larger later. Lowering ApoB runs on that same clock.

1. The Audit (ApoB and Lp(a))

We start by measuring what drives the disease.

  • ApoB: your total particle count. We aim for under 80 mg/dL in most adults, under 60 when your risk is high, and closer to 30 when it's very high.
  • Lp(a): an inherited heart attack marker that you only ever need to test once. If yours comes back high, we hold your other numbers to a tighter standard whatever they say.

2. The Verification (CTA and Cleerly AI)

Blood work gives us your odds, and imaging shows us what has already been built.

Most people get a coronary artery calcium (CAC) score, and it misses the plaque that's most likely to hurt you. It picks up calcified, hardened plaque and passes right over the soft, vulnerable kind that causes most sudden heart attacks, which is why a CAC of zero can leave you falsely reassured.

For eligible patients, we bring up a CT Coronary Angiogram (CTA) read with Cleerly AI. It measures both the calcified and the soft plaque, so we can see disease while there's still room to change it, before it hardens or ruptures.4

3. The Architecture (Intervention)

Then we build you a plan to bring ApoB down. The link here is causal, meaning these particles are the mechanism of the injury itself rather than a marker that happens to travel alongside it.2

Atherosclerotic heart disease ranks 1st among causes of death, and we think it belongs somewhere closer to 20th, because so much of it can be prevented.

  • Nutrition: fiber-rich food and a saturated fat limit that makes sense for you, set against your genetics.
  • Pharmacology: statins, PCSK9 inhibitors, or bempedoic acid for when lifestyle alone won't get you there. We treat to a target.3

Actionable Steps in Philly

Build an ApoB strategy that fits you.

  1. Get an ApoB test. Add it to whatever blood draw you have coming up. If insurance doesn't cover it, you're looking at $20 to $40 in cash.
  2. Check your Lp(a) once. Run it alongside the ApoB. It's one test, and the answer holds for the rest of your life.
  3. Know your target. Most adults are aiming for an ApoB under 80 mg/dL. Ask us where yours should be.
  4. Image when it would change the plan. If your ApoB or your family history is high, a Cleerly CTA finds soft plaque before it ruptures.
✦

Key Takeaways

  1. Test Early: Plaque can start forming in the 20s. The earlier we lower ApoB, the more compounding protection you build.
  2. Demand Lp(a): Every adult should know their Lp(a) status. It can drive heart attacks in people who "did everything right."
  3. Insulin Matters: Insulin resistance, when cells stop responding well to insulin, makes LDL particles smaller and more harmful. Fixing the metabolism helps fix the heart.

Scientific References

  1. Sniderman AD, et al. "Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review." JAMA Cardiology. 2019.
  2. Marston NA, et al. "Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction." JAMA Cardiology. 2022.
  3. Nissen SE, et al. "Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients." New England Journal of Medicine. 2023.
  4. Min JK, et al. "Coronary CTA-derived plaque characteristics and the prediction of major adverse cardiovascular events." JACC: Cardiovascular Imaging. 2022.
  5. Ference BA, Ginsberg HN, Graham I, et al. "Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease. Evidence from Genetic, Epidemiologic, and Clinical Studies. A Consensus Statement from the European Atherosclerosis Society Consensus Panel." European Heart Journal. 2017.
  6. Kanaya AM, Kandula N, Herrington D, et al. "Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study: Objectives, Methods, and Cohort Description." Clinical Cardiology. 2013;36(12):713-720.

Related Articles:

  • Lipoprotein(a): The Genetic Heart Attack Risk
  • Biological Age Testing
  • Men's Hormone Health

Dr. Ash is a board-certified internal medicine physician at Fishtown Medicine in Philadelphia. He practices Medicine 3.0 preventive cardiology so your heart lasts as long as your ambition.

Related at Fishtown Medicine

  • Borderline Cholesterol: How ApoB, Lp(a), and Blood Pressure Change the Plan - a patient case where 3 unmeasured numbers turned "recheck in a year" into a plan
  • Stroke Prevention in Philadelphia - the 2024 AHA/ASA guideline applied across BP, GLP-1, diet, CRF, and insulin resistance
  • Lp(a): The 'Widowmaker' Genetic Risk - the genetic cholesterol particle that standard panels miss, present in 1 in 5 adults
  • Lp(a) and Cholesterol - why you can have perfect cholesterol and still be at high risk
  • ED and Cardiovascular Risk - erectile dysfunction as the earliest warning sign of vascular disease
  • Longevity Medicine in Philadelphia - where ApoB fits in a full healthspan plan
  • Metabolic Health in Philadelphia - insulin resistance and ApoB travel together
  • Your Calcium Score Is High. Now What? - the workup that turns a scary calcium score into a plan, starting with ApoB
  • Health for South Asians - why heart disease comes a decade early, and the ApoB and Lp(a) workup that catches it in time
  • Why Isn't My HDL Going Up? - the lipid marker that lags behind, and why the pattern matters more than the number
  • What Is a Preventive Cardiologist? - who should lead your heart-attack prevention
  • Heart Disease in Women - why women's heart risk is different, and often missed
  • Beyond Statins: Other Ways to Lower ApoB - ezetimibe, bempedoic acid, and PCSK9 inhibitors
  • The Advanced Tests Your Doctor Isn't Ordering - the fuller panel behind ApoB
  • Macular Degeneration and AREDS2 - the eye shares the vascular health ApoB tracks
  • High Fibrinogen: What It Means for Your Heart - a risk marker that ApoB outranks as a causal, treatable lever
  • Lp-PLA2 (the PLAC Test): What It Means for Your Heart - a vascular inflammation marker that should send you back to ApoB
  • Remnant Cholesterol: The Risk Hiding in Your Standard Panel - the extra cholesterol stream ApoB already counts, and how to find it for free
Ashvin Vijayakumar MD (Dr. Ash)

Fishtown Medicine | Cardiovascular risk

2418 E York St, Philadelphia, PA 19125·(267) 360-7927·hello@fishtownmedicine.com·HSA/FSA Eligible

Start Your Intake
Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, particularly if you have chronic health conditions or are taking prescription medications.

Frequently Asked Questions

Common Questions

ApoB (apolipoprotein B) is a protein found on every cholesterol particle that can drive plaque, including LDL, VLDL, IDL, and Lp(a). Counting ApoB tells us how many of these particles are circulating, which predicts heart risk better than standard cholesterol weight.
ApoB is often covered, particularly when there is a clinical reason to test. If insurance does not cover it, the cash price is usually $20 to $40. That is a small price for one of the most useful numbers in preventive cardiology.
Not always. If your ApoB is high, we usually start with metabolic correction and diet changes, since fixing insulin resistance often lowers ApoB on its own. If genetics drive your risk, we use medication as a precise tool, not as a default.
A good ApoB range, by standard labs, is under 100 mg/dL. For optimal longevity and Medicine 3.0 standards, we target under 80 mg/dL for most adults, under 60 for high risk, and closer to 30 for very high risk patients with existing plaque or high Lp(a).
ApoB and LDL cholesterol are different because ApoB counts particles while LDL cholesterol measures the weight of cholesterol inside those particles. You can have a low LDL number with a high ApoB count, and that hidden discordance is where most missed risk lives.
Most adults should test ApoB once a year as part of routine prevention, and every three to six months when starting or adjusting a lipid-lowering medication. Stable patients can spread testing to once a year once their target is reached.
Lifestyle alone can lower ApoB significantly for many patients, particularly when insulin resistance and diet are the main drivers. For people with genetic patterns or high Lp(a), lifestyle helps but rarely brings ApoB to a safe target without medication support.
Yes, ApoB matters even if your LDL is normal. Studies show that when LDL and ApoB do not match, ApoB is the better predictor of future heart attacks. A normal LDL with a high ApoB is one of the most missed patterns in routine care.

Deep-Dive Questions

Insulin resistance changes your cholesterol particles by making them smaller, denser, and more likely to lodge in artery walls. It also raises triglycerides and lowers HDL. Treating insulin resistance with diet and movement often lowers ApoB without medication.
GLP-1 medications fit best when insulin resistance is driving the picture. When someone is insulin resistant, the metabolism churns out triglyceride-rich particles and small, dense LDL, which pushes ApoB up, so a GLP-1 that reverses that driver can bring ApoB down as it improves weight, glucose, and blood pressure. When ApoB is high without insulin resistance, a GLP-1 is not a reliable ApoB-lowering tool on its own, and a statin or another particle-directed medicine does that job better. A GLP-1 earns its place in a lipid plan through the metabolism, so we match it to the patients whose ApoB is riding on insulin resistance in the first place.
A CAC score scans only for calcified, hardened plaque, while a Cleerly CTA scans for both calcified and soft plaque using AI analysis. Soft plaque is more likely to rupture and cause a heart attack, which is why a normal CAC score can be falsely reassuring.
Soft plaque is more dangerous than calcified plaque because it has a thin cap and a fatty, inflamed core. When the cap breaks, it triggers a clot that blocks the artery, which is what causes most heart attacks. Calcified plaque is more stable.
Inflammation drives plaque by activating immune cells that attack cholesterol particles stuck in artery walls. The immune response thickens the plaque and weakens its cap. Markers like high-sensitivity CRP (a blood test for body-wide inflammation) help us track this process.
We use PCSK9 inhibitors instead of, or in addition to, statins when ApoB stays above target on a maximally tolerated statin, when patients cannot tolerate statins, or when Lp(a) is very high. PCSK9 inhibitors can lower both ApoB and Lp(a).
Bempedoic acid is an oral cholesterol-lowering pill that works in the liver by a different pathway than statins. It is for patients who cannot tolerate statins or need extra ApoB lowering. The CLEAR Outcomes trial showed it reduces heart attacks and strokes.
Yes, fiber lowers ApoB by binding bile acids in the gut, which forces the liver to use cholesterol to make new bile acids. Soluble fiber from oats, beans, and psyllium has the strongest effect. Most adults benefit from 30 to 50 grams of fiber daily.
ApoB relates to stroke risk because the same particles that drive heart artery plaque also drive plaque in the carotid (neck) and brain arteries. Lowering ApoB lowers risk of both ischemic stroke and heart attack at similar rates.
Yes, children and young adults can have high ApoB, particularly with familial hypercholesterolemia, an inherited condition that raises cholesterol from birth. We screen the kids of any patient with very early heart disease or high Lp(a), since early treatment changes outcomes dramatically.
Because arteries keep a running total. Risk from ApoB is not only how high the number is today, it is that number multiplied by the years you carry it, the same way years of high blood pressure damage a vessel long before any single reading sets off alarms. Ference and colleagues made this case directly: lowering ApoB earlier and for longer prevents far more disease than the same reduction started late, because you are shrinking the area under the curve of a lifetime of exposure.<sup>5</sup> We do not shrug off a high blood pressure in a 25-year-old because they are young, and a high ApoB deserves the same seriousness. Starting early at a low intensity usually beats starting late at a high one.
The lifestyle changes that lower ApoB the most are reducing saturated fat, increasing soluble fiber, losing visceral fat, exercising regularly, and limiting alcohol. Sleep, stress, and smoking also affect lipids through inflammation and insulin sensitivity.
Yes, there is a growing link between ApoB and dementia. The same particles that drive heart artery plaque can drive small-vessel disease in the brain, which is a major cause of vascular dementia. Lowering ApoB early may protect cognition over decades.
South Asians develop coronary artery disease and type 2 diabetes roughly a decade earlier than European-descent populations, and at lower body weights, so the usual age and BMI cues understate their risk. The MASALA study (Mediators of Atherosclerosis in South Asians Living in America), a UCSF cohort of 906 South Asian American adults, documented higher coronary artery calcium at lower BMI, high rates of diabetes and prediabetes, and elevated Lp(a) in about 25% of participants.<sup>6</sup> For South Asian patients, Fishtown Medicine runs ApoB and a one-time Lp(a) early and considers coronary calcium scoring in the 30s to 40s. Our South Asian health playbook covers the full workup.
Fishtown Medicine prioritizes ApoB testing because it gives a clearer picture of cardiovascular risk than standard panels and changes how we treat. Knowing your particle count, not just your cholesterol weight, is the foundation of a real prevention plan.

Ready when you are

Start your intake

Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.

Related Intelligence

Social Health Is Healthspan: What 80+ Years of Research Says About Relationships and Longevity

Social Health Is Healthspan: What 80+ Years of Research Says About Relationships and Longevity

More than 80 years of research connects relationships and community to how long and how well you live. A Philadelphia doctor on what to do about it day to day.

Read Deep Dive
Your Relationship With Yourself: The Ground of Every Health Change | Fishtown Medicine

Your Relationship With Yourself: The Ground of Every Health Change | Fishtown Medicine

The relationships that shape your health reach beyond other people. The first one is with yourself: the story you tell, whether you choose yourself, and how you talk to yourself when it is hard. Why that relationship decides whether a health change sticks, from Fishtown Medicine in Philadelphia.

Read Deep Dive
Borderline Cholesterol: How ApoB, Lp(a), and BP Change the Plan | A Patient Case

Borderline Cholesterol: How ApoB, Lp(a), and BP Change the Plan | A Patient Case

A 47-year-old with "borderline" LDL, a father who had a heart attack at 60, and a blood pressure nobody was tracking. How ApoB, Lp(a), and home BP turned "recheck in a year" into a plan.

Read Deep Dive

New patients

Talk it through with Dr. Ash.

Share your numbers if you know them, your family history, and what you want to get ahead of. Dr. Ash reads every intake personally.

HSA/FSA eligible
No initiation or cancellation fees
No copays
Tell Dr. Ash what’s going on →
FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
2418 E York St, Philadelphia, PA 19125Primary care in PhiladelphiaHome visits in Greater PhiladelphiaPricing & MembershipGER·O·SPAN: our clinical frameworkDigital Health Literacy

Serving Fishtown · Northern Liberties · East Kensington · Olde Richmond · Port Richmond · Old City · Callowhill · Poplar · Center City · Center City West · Art Museum · Bella Vista · Chestnut Hill · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark · Bryn Mawr, PA · Gladwyne, PA · Villanova, PA · Wayne, PA · Cherry Hill, NJ · Haddonfield, NJ · Medford, NJ · Moorestown, NJ · Voorhees, NJ

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • Testosterone (TRT)
  • Sleep Apnea & Low T
  • Andropause
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack
  • Supplement Guides
Care in Philadelphia +
Direct Primary Care in Philadelphia, PAConcierge Medicine in Philadelphia, PAConcierge vs DPC in Philadelphia, PALongevity Medicine in Philadelphia, PAPreventive Care in Philadelphia, PAExecutive Physical in Philadelphia, PAAnnual Physical in Philadelphia, PAHealthspan Optimization in Philadelphia, PAFunctional Medicine in Philadelphia, PASame-Day Sick Visits in Philadelphia, PATestosterone Replacement Therapy in Philadelphia, PAPerimenopause Care in Philadelphia, PAMenopause Care in Philadelphia, PAThyroid Treatment in Philadelphia, PAPCOS Care in Philadelphia, PAGLP-1 Weight Loss in Philadelphia, PAMetabolic Health in Philadelphia, PAHormone Optimization in Philadelphia, PAAdvanced Lipid Testing in Philadelphia, PAVO2 Max Testing in Philadelphia, PADEXA Scan in Philadelphia, PACGM in Philadelphia, PALong COVID Care in Philadelphia, PAChronic Fatigue Treatment in Philadelphia, PAPOTS Treatment in Philadelphia, PAMCAS Treatment in Philadelphia, PALyme Disease Care in Philadelphia, PABrain Fog Treatment in Philadelphia, PASleep Disorders Treatment in Philadelphia, PAStrep Throat Treatment in Philadelphia, PAUTI Treatment in Philadelphia, PASinus Infection Treatment in Philadelphia, PASTI Testing in Philadelphia, PATravel Medicine in Philadelphia, PAPre-Op Clearance in Philadelphia, PASports Club Medicine in Philadelphia, PA

Made it this far? You’re already most of the way there. let’s get started → Dr. Ash reads every word personally.

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical Independence